Axonics specializes in sacral neuromodulation therapy, a clinically proven treatment designed to alleviate symptoms associated with bladder and bowel control issues, such as overactive bladder, bowel incontinence, and urinary retention. This innovative therapy aims to restore normal function by targeting the sacral nerves, which play a crucial role in bladder and bowel control. The Axonics system offers a discreet and user-friendly device that allows patients to experience the therapy's effectiveness before committing to long-term treatment. With a high satisfaction rate among users, Axonics Therapy has been shown to provide significant symptom relief and improve the quality of life for many individuals suffering from these conditions.

The Axonics Therapy system is notable for its long-lasting results and ease of use. Patients can manage their therapy with simple tools, making it accessible for those seeking relief from frequent bathroom trips and accidents. The technology has demonstrated impressive clinical outcomes, with a significant percentage of patients reporting substantial improvements in their symptoms over a two-year period. As part of Boston Scientific, Axonics continues to advance its offerings in the field of neuromodulation, focusing on enhancing patient experiences and outcomes through innovative medical solutions.

United States

Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology. The Axonics Sacral Neuromodulation System™ is the first CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction (not available in the US).

Axonics

Company Details